Literature DB >> 32255286

Clinical Accuracy of a New Rapid Assay for Fecal Calprotectin Measurement.

Olga Ashorov, Dalal Hamouda, Ram Dickman, Tsachi Tsadok Perets.   

Abstract

BACKGROUND: Fecal calprotectin is an excellent biomarker for distinguishing inflammatory bowel disease from irritable bowel syndrome and for evaluation of disease activity in Crohn's disease and ulcerative colitis. The aim of this work was to evaluate the analytical performance of a new flow immune chromatography assay by comparing it to our standardized laboratory gold standard system.
METHODS: A total of 100 stool samples sent for routine calprotectin level measurements were analyzed by the Liaison XL system and the QuantOn Cal assay simultaneously using the same cutoff values for both assays. Performance of the QuantOn Cal assay was assessed by calculating sensitivity, specificity, and accuracy.
RESULTS: Compared with the gold standard, the sensitivity, specificity, and accuracy of the QuantOn Cal assay were 98.7%, 76.2%, and 94.0%, respectively. Furthermore, linear correlation of calprotectin levels between the two assays were found to be significant by Pearson's correlation coefficient test (r = 0.82, p-values < 0.0001).
CONCLUSIONS: The QuantOn Cal assay demonstrated good performance, both qualitative and quantitative when compared to the Liaison XL system. This novel and rapid assay is well suited for measuring fecal calprotectin as a point of care or home-based assay when laboratory services are limited or not available.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32255286     DOI: 10.7754/Clin.Lab.2020.200126

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  3 in total

1.  Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease.

Authors:  Renske W M Pauwels; Christien J van der Woude; Nicole S Erler; Annemarie C de Vries
Journal:  Therap Adv Gastroenterol       Date:  2020-12-24       Impact factor: 4.409

2.  Lactobacillus rhamnosus GG (ATCC 53103) for the Management of Infantile Colic: A Randomized Controlled Trial.

Authors:  Francesco Savino; Paola Montanari; Ilaria Galliano; Valentina Daprà; Massimiliano Bergallo
Journal:  Nutrients       Date:  2020-06-05       Impact factor: 5.717

3.  Serum Serotonin Differentiates Between Disease Activity States in Crohn's Patients.

Authors:  Christopher R Manzella; Dulari Jayawardena; Wilfredo Pagani; Ye Li; Waddah A Alrefai; Jessica Bauer; Barbara Jung; Christopher R Weber; Ravinder K Gill
Journal:  Inflamm Bowel Dis       Date:  2020-09-18       Impact factor: 7.290

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.